Biodesix to report third quarter 2021 financial results on november 15, 2021

Boulder, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it will release financial results for the third quarter ended september 30, 2021 before the open of trading on monday, november 15. biodesix's management will host a conference call and webcast to discuss its financial results and provide a general business update at 9:00 a.m. eastern time on the same day. dial-in and call details
BDSX Ratings Summary
BDSX Quant Ranking